NIH-funded research NIH-funded research

Investigating how delta-9-tetrahydrocannabinol affects cell structures in HIV infection.

Official title: Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.

Funded at New York Medical College · NIH-10890889 · Data updated 2026-11-12

This study is looking at how a compound found in cannabis, THC, might help reduce inflammation and improve symptoms in people with HIV by affecting certain cell structures during the infection.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York Medical College
NIH-funded
Lab location1 site (Valhalla, United States)
Project startApril 15, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$436,546
NIH project number5R33DA053643-04
Project IDNIH-10890889 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals living with HIV who are interested in exploring the effects of THC on their condition.

Less likely to help

Patients who are not living with HIV or do not have a related condition may not receive any benefit from this research.

What this research studies

This research explores the role of membraneless condensates in cells and how they are influenced by delta-9-tetrahydrocannabinol (THC) during HIV infection. By examining the physicochemical properties of these structures, the study aims to understand their impact on viral replication and inflammation. Patients may benefit from insights into how THC could potentially alleviate symptoms associated with HIV. The research employs advanced biochemical techniques to analyze the interactions between THC and cellular components.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing HIV infection and its associated symptoms.

How similar studies have gone: Previous research has shown promising results regarding the effects of THC on HIV-related symptoms, suggesting that this approach may yield valuable insights.

Where this research is happening

  • New York Medical College
    Valhalla, United States
    Active

Researchers

  • Principal investigator: Okeoma, Chioma M — New York Medical College
  • Study coordinator: Okeoma, Chioma M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.